Dr Gerald Jacob Barron I, MD | |
71 Puakea Pl, Kula, HI 96790-8129 | |
(808) 878-6547 | |
Not Available |
Full Name | Dr Gerald Jacob Barron I |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 71 Puakea Pl, Kula, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659411247 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | AB1044015 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Gerald Jacob Barron I, MD 71 Puakea Pl, Kula, HI 96790-8129 Ph: (808) 878-6547 | Dr Gerald Jacob Barron I, MD 71 Puakea Pl, Kula, HI 96790-8129 Ph: (808) 878-6547 |
News Archive
Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that Sumisho Computer Systems Corporation (SCS) has become the first IT systems integration services provider to join Medidata's ASPire to Win® program for contract research organizations (CROs) and service providers.
Sleep Revolution, an interdisciplinary international research and development project, has been selected for a 15-million Euro grant from the EU's Horizon 2020 Framework Programme for Health, demographic change and wellbeing.
The KeyBank Foundation has announced a grant of $2 million to Cleveland Clinic and Case Western Reserve University (CWRU) which will support a combined effort to enhance and expand medical students' interprofessional education experiences.
State legislatures around America are considering laws to change their Medicaid programs and to address how patients can learn their doctor's malpractice history. They are also contemplating how to cut health care costs and adjusting prescription privileges for nurses.
Indiana University researchers have detected new early-warning signs of the potential loss of sight associated with diabetes. This discovery could have far-reaching implications for the diagnosis and treatment of diabetic retinopathy, potentially impacting the care of over 25 million Americans.
› Verified 6 days ago